GlobeNewswire by notified

Statkraft to start construction of 80 MW wind power project in Brazil

Share

(Florianopolis/Oslo, 14 January 2022) Statkraft is ready to start construction of its Morro do Cruzeiro wind project in northeastern Brazil, after closing a turbine supply contract with German wind turbine manufacturer Nordex.

Morro do Cruzeiro is a greenfield wind project, developed by Statkraft in Brazil. The project entails two wind farms, 14 turbines and a total installed capacity of 80 MW. The wind farms are located in the state of Bahia, close to Statkraft’s existing wind power assets. Given the excellent wind conditions in the area, the project will generate 386 GWh of renewable energy per year, enough to power more than 190,000 Brazilian homes.

The wind project is being implemented in accordance with Brazil’s strict environmental and social permitting and monitoring systems, and Statkraft’s international standards. The wind farms have limited land acquisition, no resettlement, low environmental impact and no impact on red-listed species. In addition, Statkraft will carry out Corporate Social Responsibility (CSR) activities for nearby communities, focused on education and infrastructure improvements.

Construction will start in June 2022, the first wind turbines are expected to start operation in October 2023 and completion is scheduled by beginning of 2024. The project will utilise the Nordex N163/5.7 MW wind turbine, the largest onshore wind turbines used by Statkraft to date. With a diameter of 163 meters, the rotors will cover an area equal to almost 3 standard football pitches.

The renewable energy generation from the wind farms will cover commitments from the public auction last autumn. Remaining energy will be sold in the free market.

“Statkraft's ambition in Brazil is to be a significant developer and operator of hydro, wind and solar power. The Morro do Cruzeiro project brings us closer to achieving this,” says Country Manager Brazil, Fernando de Lapuerta.

“I’m very happy to see our teams develop such a competitive project inhouse. Construction of Morro do Cruzeiro is part of Statkraft’s growth strategy in Brazil and together with our 520 MW Ventos de Santa Eugenia project, this significantly contributes to reaching our Group-wide goal of developing 6 GW of wind power globally by 2025,” says EVP International Power, Jürgen Tzschoppe.

Brazil is mainly a hydropower country, while wind power now has a share of 11 percent of the total power generating capacity. Brazilian wind power installation is expected to grow from around 21 GW today to 32 GW by 2026, according to the Brazilian Wind Energy Association, ABEEólica.

Statkraft has been present in Brazil since March 2012 and currently has a portfolio of 18 wind- and hydropower plants with a total installed capacity of 450 MW. The completion of the two wind projects Morro do Cruzeiro and Ventos de Santa Eugenia, currently under construction, will more than double the installed capacity to 1050 MW.


About Statkraft

Statkraft is a leading company in hydropower internationally and Europe’s largest generator of renewable energy. The Group produces hydropower, wind power, solar power, gas-fired power and supplies district heating. Statkraft is a global company in energy market operations. Statkraft has 4,600 employees in 18 countries.

Media contacts: 

Brazil

Race Comunicação
Rodrigo Freitas | Daniele Candido | Michele Colombo
Phone:+55 (11) 94039-5658
E-mail: imprensa.statkraft@agenciarace.com.br

International

Lars Magnus Günther, press spokesperson Statkraft AS
E-mail: lars.gunther@statkraft.com
Phone: +47 91241636


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates16.8.2022 09:01:00 CEST | Press release

– ColoAlert to be marketed through Dante’s extensive database and sold via its region-specific, ecommerce websites – BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz'' or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, and Dante Genomics, a global leader in genomics and precision medicine, announced today the formal commencement of ColoAlert’s consumer commercial program in Italy and the United Arab Emirates (UAE). ColoAlert is Mainz’s flagship product, a highly efficacious and easy to use, at-home detection test for colorectal cancer (CRC) currently being commercialized across Europe and select international markets. With the ColoAlert test CE-IVD certified and patient collection kit CE marked to the latest IVDR requirements, ColoAlert will now be marketed through Dante’s extensive database and sold via Dante’s, region-specific, ecommerce websites. “This is

Cody Patrick Named OEM Direct Sales Manager for Nikkiso Clean Energy and Industrial Gases Group16.8.2022 09:01:00 CEST | Press release

TEMECULA, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Cody Patrick has been named OEM Direct Sales Manager for Nikkiso ACD, a part of the Cryogenic Pumps unit of Nikkiso’s Clean Energy & Industrial Gases Group. Cody is a graduate of Texas A&M College of Engineering’s Industrial Distribution program. The combination of his education and experience with Cryogenic pumps for the industrial gases market, make him well suited to assist with growing the U.S. market. He will manage and develop business strategies and opportunities as well as assist with the development of training and educational programs for the Group’s clients. Cody will be based in Houston and report to Ian Guthrie, Business Line Manager for the Group’s Cryogenic Pumps unit. “Given Cody’s enthusiasm and understanding of the cryogenic pumps market we are excited t

Ahold Delhaize share buyback update16.8.2022 08:00:00 CEST | Press release

Zaandam, the Netherlands, August16, 2022 – Ahold Delhaize has repurchased 254,408 of its common shares in the period from August 8, 2022 up to and including August 12, 2022. The shares were repurchased at an average price of € 27.21 per share for a total consideration of € 6.9 million. These repurchases were made as part of the € 1 billion share buyback program announced on November 15, 2021. The total number of shares repurchased under this program to date is 20,621,088 common shares for a total consideration of € 561.6 million. Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2022/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.

Sanionas Kv7-program för epilepsi avanceras till leadoptimering16.8.2022 08:00:00 CEST | Pressemelding

PRESSMEDDELANDE 16 augusti 2022 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling, meddelar idag att bolaget har avancerat sitt lovande Kv7-program för epilepsi till fasen leadoptimering – den sista fasen av läkemedelsupptäckt innan en klinisk kandidat väljs ut. Thomas Feldthus, VD: ”Vi tror att vi har löst knäckfrågorna för att utveckla nästa generation av läkemedelskandidater av den här klassen, och vi ser en betydande potential att ta fram nya banbrytande epilepsibehandlingar. Finansiellt kan uppsidan vara avsevärd, att döma av vissa viktiga läkemedelsavtal som nyligen slutits på Kv7-området.” Miljontals människor runt om i världen påverkas i dag av epilepsi, en sjukdom som kännetecknas av återkommande krampanfall. Det medicinska behovet är stort, eftersom omkring 30 procent av patienterna inte svarar på behandling med konventionella läkemedel mot epilepsi. Läkemedel mot kramper kan desutom ha funktionshämmande biverkningar, som ofta måste minimeras genom no

Saniona progresses its Kv7 epilepsy program into Lead Optimization16.8.2022 08:00:00 CEST | Press release

PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it has progressed its promising Kv7 epilepsy program into the Lead Optimization Phase, which is the last drug discovery phase before potential selection of a clinical candidate. Thomas Feldthus, CEO: “We believe that we have cracked the main challenges for making the next generation drug candidates of this class and see significant potential for delivering new breakthrough epilepsy treatments. The financial upside could be substantial based on very significant pharma deals recently executed in the Kv7 field”. Epilepsy, characterized by recurrent seizures, currently affects millions of people worldwide. There is a significant medical need as approximately 30% of patients are insensitive to treatment by conventional epilepsy medicines. Furthermore, anti-seizure therepy may cause disabling side effects and often require careful dose adjustment to minimize these. Kv7 ion ch